Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


Advances and Progress in Drug Design

18 Feb 2013 - 19 Feb 2013 - London, UK



Bookmark and Share


SMi is proud to present their 12th annual conference on Drug Design. 

This exciting event will focus on the latest developments in this fast-paced field and bring together senior representatives from industry and academia to discuss Statistical Issues in CADD, Binding Site Solvent Analysis, Structure-Based Lead Discovery and G-protein-coupled receptors.

This unique conference will provide an unparalleled opportunity for debate and problem solving of key challenges currently facing the field, allowing attendees to discuss progress in the area and exchange ideas moving forward, ensuring a truly comprehensive treatment of the most important issues.

KEY BENEFITS OF ATTENDING:

Consider computational approaches to polypharmacology and mode-of-action analysis

Understand applications of CADD to protein therapeutics

Evaluate drug design strategies for anti-virals and combating resistance 

Discover the latest development in water network perturbation in structure-based drug design

Discuss the discovery of novel inhibitors through structure-based fragment evolution

Hear from the industry on the influence of kinetic and thermodynamic signatures on hit-and-lead optimization

Capitalize on the latest in data integration and developments in public-private partnerships

Network and learn from key opinion leaders from industry and academia on protein-protein interactions

Visit our website here: http://www.smi-online.co.uk/2013drugdesign11.asp

Farhaana Rahman on tel: +44 (0) 20 7827 6186 or email: frahman@smi-online.co.uk

Quote “Technology Network” and save £100




Further information
Scientific News
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Spotting DNA Repair Genes Gone Awry
Ludwig researchers develop a two-pronged approach for identifying genes responsible for fixing DNA damage that can trigger cancer when compromised.
Interpreting “Dark Matter” DNA
Scientists at the Gladstone Institutes have invented a new way to read and interpret the human genome.
A Programming Language for Living Cells
New language lets researchers design novel biological circuits.
The Epigenetics of Childhood Cancer
Qlucore software enables researchers to more easily study the genetic influences behind childhood cancer.
Mining Whole Exome Data to Improve Cancer Therapies
New tool interprets the raw data of whole exome tumor sequencing and then matches the cancer’s unique genetics to FDA-approved targeted treatments.
Pittcon 2016: Accelerating Innovation And Enhancing Productivity With Technology
Collaboration and externalization of data highlight evolving lab operations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!